Cipla celebrates 90 years with focus on quality products, global presence, and investment in research and technology.

Though long-term prospects appear sound, near-term earnings visibility remains limited for Dr. Reddy's Labs, Cipla, and Lupin ...

Mumbai-headquartered drugmaker Cipla Ltd is bolstering its focus on a pipeline of drugs to fight infections caused by ...

With a rise in COVID cases and seasonal flu, Cipla Health's trusted portfolio empowers everyday health decisions for Indian families MUMBAI, India, July ...

The healthcare sector, particularly pharmaceuticals and hospitals, have demonstrated strong performance in the March 2025 quarter, with revenue growth exceeding that of Nifty 500 companies. Even ...

Shift is expected to drive a sharp increase in generic drug launches, positioning Indian drugmakers for strong growth ...

Cipla USA is a respiratory leader, ranking #2 in inhaler sales globally and in the top 3 for US generic respiratory sales (IQVIA TRx data as of February 2025).